257 related articles for article (PubMed ID: 32222732)
1.
Sachpekidis C; Exadaktylou P; Katsampoukas D; Moralidis E; Arsos G
Hell J Nucl Med; 2020; 23(1):76-78. PubMed ID: 32222732
[TBL] [Abstract][Full Text] [Related]
2. 18F-FDG PET/CT for staging and response assessment of primary parotid MALT lymphoma with multiple sites involvement: A case report.
Ren Y; Huang L; Han Y; Cui Z; Li J; Dong C; Liu J
Medicine (Baltimore); 2019 Feb; 98(5):e14270. PubMed ID: 30702589
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of interim PET/CT response for the treatment of advanced-stage marginal zone lymphoma in the post-rituximab era.
Song GY; Yoon SE; Kim SJ; Kim JS; Koh Y; Moon JH; Oh SY; Lee HS; Shin HJ; Do YR; Lee WS; Kim DS; Park Y; Yhim HY; Yang DH
Sci Rep; 2020 Jul; 10(1):11649. PubMed ID: 32669642
[TBL] [Abstract][Full Text] [Related]
4. [A Case of Peritoneal Lymphomatosis Diagnosed by Single-Port Laparoscopic Biopsy].
Miyazaki Y; Tokuyama S; Fukuda Y; Michiura T; Hayashi N; Morimoto M; Yokoya Y; Yamabe K
Gan To Kagaku Ryoho; 2022 Dec; 49(13):1950-1952. PubMed ID: 36733054
[TBL] [Abstract][Full Text] [Related]
5. High-grade B-cell lymphoma, not otherwise specified, presenting as primary peritoneal lymphomatosis and successfully treated with dose-adjusted EPOCH-R.
Fujimi A; Nagamachi Y; Yamauchi N; Onoyama N; Hayasaka N; Matsuno T; Koike K; Goto Y; Ihara K; Kato J; Nishisato T; Kawase H; Yano T; Kanaseki T; Sugita S; Kobune M
J Clin Exp Hematop; 2024 Mar; 64(1):37-44. PubMed ID: 38281744
[TBL] [Abstract][Full Text] [Related]
6. Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas (PETAL): A Multicenter, Randomized Phase III Trial.
Dührsen U; Müller S; Hertenstein B; Thomssen H; Kotzerke J; Mesters R; Berdel WE; Franzius C; Kroschinsky F; Weckesser M; Kofahl-Krause D; Bengel FM; Dürig J; Matschke J; Schmitz C; Pöppel T; Ose C; Brinkmann M; La Rosée P; Freesmeyer M; Hertel A; Höffkes HG; Behringer D; Prange-Krex G; Wilop S; Krohn T; Holzinger J; Griesshammer M; Giagounidis A; Raghavachar A; Maschmeyer G; Brink I; Bernhard H; Haberkorn U; Gaska T; Kurch L; van Assema DME; Klapper W; Hoelzer D; Geworski L; Jöckel KH; Scherag A; Bockisch A; Rekowski J; Hüttmann A;
J Clin Oncol; 2018 Jul; 36(20):2024-2034. PubMed ID: 29750632
[TBL] [Abstract][Full Text] [Related]
7. 18F-FDG-PET/CT Pulmonary Infiltrates in Non-Hodgkin Lymphoma Patients Treated with Combined Immunochemotherapy: Incidence and Clinical Characteristics.
Cohen YC; Berger T; Eshel L; Stern D; Bairey O; Raanani P; Shpilberg O
Isr Med Assoc J; 2017 Jun; 19(6):372-377. PubMed ID: 28647936
[TBL] [Abstract][Full Text] [Related]
8. Treatment Resulting Changes in Volumes of High-
Huang YM; Hsieh CH; Wang SY; Tsao CH; Lee JC; Chen YJ
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768479
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of PET/CT evaluation with Deauville score on the recurrence and survival in diffuse large B-cell lymphoma: a multi-institutional study of KROG 17-02.
Lee JW; Oh D; Eom KY; Kim JH; Kim WC; Chung MJ; Lee JH
Clin Exp Metastasis; 2020 Feb; 37(1):125-131. PubMed ID: 31555945
[TBL] [Abstract][Full Text] [Related]
10. A rare involvement of diffuse large B-cell lymphoma: Peritoneal lymphomatosis with a peritoneal super-scan appearance on
Yılmaz F; Önner H
Hell J Nucl Med; 2022; 25(1):103-105. PubMed ID: 35388807
[TBL] [Abstract][Full Text] [Related]
11. Strikingly high false positivity of surveillance FDG-PET/CT scanning among patients with diffuse large cell lymphoma in the rituximab era.
Avivi I; Zilberlicht A; Dann EJ; Leiba R; Faibish T; Rowe JM; Bar-Shalom R
Am J Hematol; 2013 May; 88(5):400-5. PubMed ID: 23423884
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of initial 18F-FLT uptake in patients with aggressive non-Hodgkin lymphoma receiving R-CHOP treatment.
Herrmann K; Buck AK; Schuster T; Junger A; Wieder HA; Graf N; Ringshausen I; Rudelius M; Wester HJ; Schwaiger M; Keller U; Dechow T
J Nucl Med; 2011 May; 52(5):690-6. PubMed ID: 21498532
[TBL] [Abstract][Full Text] [Related]
13. 18F-fluorodeoxyglucose positron emission tomography/computed tomography findings in mucosa-associated lymphoid tissue lymphoma of the larynx: a case report and literature review.
Zhao K; Luo YZ; Zhou SH; Dai BL; Luo XM; Yan SX; Wang QY; Ling L
J Int Med Res; 2012; 40(3):1192-206. PubMed ID: 22906294
[TBL] [Abstract][Full Text] [Related]
14. Combined modality treatment for PET-positive non-Hodgkin lymphoma: favorable outcomes of combined modality treatment for patients with non-Hodgkin lymphoma and positive interim or postchemotherapy FDG-PET.
Halasz LM; Jacene HA; Catalano PJ; Van den Abbeele AD; Lacasce A; Mauch PM; Ng AK
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e647-54. PubMed ID: 22607911
[TBL] [Abstract][Full Text] [Related]
15. Integration of CT-Based Measurements into Surveillance PET/CT in Patients with Diffuse Large B Cell Lymphoma.
Lavi N; Shapira G; Zilberlicht A; Benyamini N; Farbstein D; Dann EJ; Bar-Shalom R; Avivi I
Isr Med Assoc J; 2016 Jul; 18(7):411-417. PubMed ID: 28471564
[TBL] [Abstract][Full Text] [Related]
16. Burkitt post-transplantation lymphoma in adult solid organ transplant recipients: sequential immunochemotherapy with rituximab (R) followed by cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or R-CHOP is safe and effective in an analysis of 8 patients.
Zimmermann H; Reinke P; Neuhaus R; Lehmkuhl H; Oertel S; Atta J; Planker M; Gärtner B; Lenze D; Anagnostopoulos I; Riess H; Trappe RU
Cancer; 2012 Oct; 118(19):4715-24. PubMed ID: 22392525
[TBL] [Abstract][Full Text] [Related]
17. Primary chest wall Burkitt lymphoma in a case of HIV infection with immune reconstitution.
Jain A; Arun VA; Bal A; Malhotra P
BMJ Case Rep; 2021 Dec; 14(12):. PubMed ID: 34969787
[TBL] [Abstract][Full Text] [Related]
18. Aggressive extensive cardiac mass in an HIV-1-infected patient: should we go for comfort therapy?
Vervloet DM; De Pauw M; Demulier L; Vercammen J; Terryn W; Steel E; Vandekerckhove L
Acta Clin Belg; 2017 Jun; 72(3):198-200. PubMed ID: 27355914
[TBL] [Abstract][Full Text] [Related]
19. Disseminated Lymphoma Evolving into Neurolymphomatosis during Mid-cycle of Chemotherapy Detected by (18)F-FDG PET/CT.
Tong AK; Neo SH; Kok TY
Ann Acad Med Singap; 2015 Nov; 44(11):545-7. PubMed ID: 27089963
[No Abstract] [Full Text] [Related]
20. Mucosa-associated lymphoid tissue lymphoma with unusual
Zhang NS; Shi F; Kong L; Zhu H
World J Gastroenterol; 2017 Jan; 23(3):551-559. PubMed ID: 28210093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
